About the Lab
The Everett Lab is dedicated to advancing diabetes care through innovative clinical and health services research. A major focus of our work is improving access to and effective use of diabetes technologies, such as insulin pumps and continuous glucose monitors (CGMs), particularly among populations at high risk for poor diabetes outcomes.
We study how these technologies are used in real-world settings and identify factors that support or hinder their adoption. Our research is multifaceted, exploring everything from the impact of healthcare policies to the psychosocial and behavioral aspects of diabetes management. Through this work, we design and evaluate interventions aimed at improving outcomes for individuals with poorly controlled type 1 and type 2 diabetes.
Based at UCLA, the Everett Lab takes a multidisciplinary approach and partners with community health centers, academic institutions, and patients to drive meaningful, data-driven improvements in diabetes care.
About the PI
PRINCIPAL INVESTIGATOR
Dr. Estelle Everett is an Assistant Professor of Medicine at UCLA and a board-certified endocrinologist with specialized training in health services research. Her work is driven by both her clinical experience and a personal connection to diabetes, fueling her deep commitment to advancing diabetes care.
By integrating clinical insight with rigorous research methods, Dr. Everett brings a unique perspective to understanding how real-world systems, policies, and patient experiences influence diabetes management.
As Principal Investigator of the Everett Lab, she leads a multidisciplinary team focused on designing and evaluating innovative, patient-informed interventions to improve diabetes care and outcomes. Her research is supported by funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health, as well as the Robert Wood Johnson Foundation’s Harold Amos Medical Faculty Development Program (AMFDP).
Publications
Everett E, Dao L, Munaganuru N, Udeze K, Gutierrez S, Gann S, Meda A, Tiu R, Arevallo A, Drexler A, Abdulrahman Y, Santana C, Moin T. Determining Insulin Pump Candidacy: The Disconnect between Clinical Care Guidelines and Clinical Practice. Journal of the Endocrine Society, bvaf068
Moolchandani P, Patel S, Larsen T, Moriates C, Weinreb J, Everett E, Targeting insulin stacking to address overnight hypoglycaemia in hospitalized patients with diabetes: BMJ Open Quality 2025;14:e003178.
Chan J, Jackson N, Gonzalez Rebeollar A, Santana C, Perez de la Garza G, Moin T. Yee J. Everett E. Association between self-monitored blood glucose, continuous glucose monitor use, and diabetes outcomes in youths with type 1 diabetes and public insurance. Diabetes Care 2025;48(4):632–638
Everett E, Ham C, Richley M, Copeland T, Moin T, Wisk L. Preterm Labor and Hypertensive Disorders in Adolescent Pregnancies With Diabetes Between 2006 and 2019. Pediatric Diabetes. 2024; 2024(0). https://doi.org/10.1155/2024/2283730
Everett EM. Leveraging Continuous Glucose Monitors to Reduce the Risk of Diabetic Retinopathy. JAMA Network Open. 2024;7(3):e240718. doi:10.1001/jamanetworkopen.2024.0718
Kanbour s and Everett E. Addressing Disparities in Technology Use Among Patients with Type 1 Diabetes: A Review. Current Opinion in Endocrinology and Diabetes. Current Opinion in Endocrinology, Diabetes and Obesity. 2024 Feb; 31(1):14-21
American Diabetes Association Diabetes Technology Interest Group (Akturk, H. K., Group, A. D. A. D. T. I., Aloi, J., Shah, V. N., Akturk, H. K., McKee, A. M., Ekhlaspour, L., Kim, S., & Everett, E). (2024). Recent Advances in Diabetes Technology and Activities of the American Diabetes Association Diabetes Technology Interest Group. Clinical Diabetes. https://doi.org/10.2337/CD23-0080
Estelle M. Everett, Timothy Copeland, Lauren E. Wisk, Lily C. Chao, “Risk Factors for Hyperosmolar Hyperglycemic State in Pediatric Type 2 Diabetes”, Pediatric Diabetes, 2023;2023:1318136. doi: 10.1155/2023/1318136
Everett E, Wright D, Williams A, Divers J, Pihoker C, Liese A, Bell R, Bellatorre A, Kahkoska A, Mayer-David E, Mendoza J, Wisk L. Assessing Longitudinal Disparities in Insulin Pump Use Among Youth with Type 1 Diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Technol Ther. 2023 Feb;25(2):131-139. doi: 10.1089/dia.2022.0340
Kanbour S, Jones M, Abusamaan M, Nass C, Everett E, Wolf R, Sidhaye, MD A, Mathioudakis N. Racial Disparities in Diabetes Technology Discussions, Prescribing and Use Among Adult Patients with Type 1 Diabetes in a U.S. Academic Medical Center. Diabetes Care. 2023 Jan 1;46(1):56-64. doi: 10.2337/dc22-1055.
Mathioudakis N, Everett E, Golden SH. Prevention and management of insulin-associated hypoglycemia in hospitalized patients. Endocrine Practice. 2016 Aug 22; (8):959-69. Â
Everett E, Copeland T, Moin T, Wisk L. Insulin Pump Related Inpatient Admissions in a National Sample of Youth with Type 1 diabetes. Journal of Clinical Endocrinology & Metabolism. 2022 Feb 23;dgac047.
Everett E, Wisk LE. Relationships Between Socioeconomic Status, Insurance Coverage for Diabetes Technology and Adverse Health in Patients With Type 1 Diabetes. J Diabetes Sci Technol. 2022 Jul;16(4):825-833. doi: 10.1177/19322968211050649. Epub 2021 Oct 9.
Everett E, Copeland T, Moin T, Wisk L. National Trends in Pediatric Admissions for Diabetic Ketoacidosis, 2006-2016. Journal of Clinical Endocrinology & Metabolism. 2020 Jul 13;106(8):2343-2354. doi: 10.1210/clinem/dgab287.
Mathioudakis N, Jeun R, Godwin G, Perschke A, Yalamanchi S, Everett E, Greene P, Knight A, Yuan C, and Golden SH. Development and Implementation of a Subcutaneous Insulin Clinical Decision Support Tool for Hospitalized Patients. Journal of Diabetes Science and Technology. 2018 Sept; 1938296818798036.
Everett E and Mathioudakis N. Associations of Socioeconomic Status and Diabetic Ketoacidosis Readmissions: a Comparative Risk Analysis of Adults versus Children. Journal of Clinical Endocrinology & Metabolism. 2019 Aug 1;104(8):3473-3480.
Everett E and Mathioudakis N. Associations of Socioeconomic Status and DKA Readmission Among Adults with Type 1 Diabetes in the United States. BMJ Open Diabetes Research & Care. 2019. April;8(1):e000621
Everett E and Mathioudakis N. Inpatient Glycemic Management of Non-Cardiac Cardiovascular Disease. Current Diabetes Reports. 2018 Jun; (8):49.
Mathioudakis N, Everett E, Routh S, Pronovost P, Yeh H, Golden SH, and Saria S. Development and Validation of a Prediction Model for Insulin-Associated Hypoglycemia in Non-Critically Ill Hospitalized Adults. BMJ Open Diabetes Research & Care. 2018 Mar; 6(1):e000499.
Everett E, Kane B, Yoo A, Dobs A, Mathioudakis A, A Novel Approach for Large-Scale, Personalized, Artificial Intelligence-Based Health Coaching for Adults with Prediabetes: Feasibility and Effectiveness Results of a Pilot Study. Journal of Medical Internet Research. 2018 Feb: 20(2):e72.
Everett E and Mathioudakis N. Update on management of diabetic foot ulcers. Annals of the New York Academy of Sciences. 2018 Jan;1411(1):153-165.
